SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 119 filers reported holding SUTRO BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $318,877 | -23.5% | 91,898 | +2.5% | 0.00% | – |
Q2 2023 | $416,863 | +106514.6% | 89,648 | +5.8% | 0.00% | – |
Q1 2023 | $391 | -37.7% | 84,696 | +8.9% | 0.00% | -100.0% |
Q4 2022 | $628 | -99.8% | 77,771 | +9.6% | 0.00% | 0.0% |
Q3 2022 | $394,000 | +20.5% | 70,984 | +13.1% | 0.00% | – |
Q2 2022 | $327,000 | -28.0% | 62,756 | +13.7% | 0.00% | -100.0% |
Q1 2022 | $454,000 | -45.5% | 55,176 | -1.4% | 0.00% | 0.0% |
Q4 2021 | $833,000 | -20.1% | 55,973 | +1.3% | 0.00% | 0.0% |
Q3 2021 | $1,043,000 | +5.5% | 55,236 | +3.8% | 0.00% | 0.0% |
Q2 2021 | $989,000 | +48.5% | 53,211 | +81.9% | 0.00% | 0.0% |
Q1 2021 | $666,000 | +10.6% | 29,251 | +5.6% | 0.00% | 0.0% |
Q4 2020 | $602,000 | +192.2% | 27,711 | +35.1% | 0.00% | – |
Q3 2020 | $206,000 | +41.1% | 20,510 | +9.3% | 0.00% | – |
Q2 2020 | $146,000 | +3.5% | 18,773 | +36.1% | 0.00% | – |
Q1 2020 | $141,000 | -7.2% | 13,798 | 0.0% | 0.00% | – |
Q4 2019 | $152,000 | +23.6% | 13,798 | +1.6% | 0.00% | – |
Q3 2019 | $123,000 | -12.8% | 13,578 | +9.3% | 0.00% | – |
Q2 2019 | $141,000 | – | 12,422 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |